In vitro interaction of HMG-CoA reductase inhibitors (statins) with MDR1, MRP2, and OATP-C

被引：0
|
作者：
Chen, CP [1 ]
Mireles, R [1 ]
Campbell, S [1 ]
Lin, J [1 ]
Mills, J [1 ]
Xu, J [1 ]
Smolarek, T [1 ]
机构：
[1] Pfizer Inc, Groton Lab, Groton, CT 06340 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
303
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [41] The expanding role of HMG-CoA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease
    Chilton, R
    O'Rourke, RA
    CURRENT PROBLEMS IN CARDIOLOGY, 2001, 26 (12) : 734 - 764
  • [42] Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women
    Markowska, Anna
    Antoszczak, Michal
    Markowska, Janina
    Huczynski, Adam
    PHARMACEUTICALS, 2020, 13 (12) : 1 - 13
  • [43] Multiple effects of HMG-CoA reductase inhibitors (statins) besides their lipid-lowering function
    Haslinger-Loeffler, Bettina
    KIDNEY INTERNATIONAL, 2008, 74 (05) : 553 - 555
  • [44] Drug interactions with HMG-CoA reductase inhibitors (statins): The importance of CYP enzymes, transporters and pharmacogenetics
    Neuvonen, Pertti J.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (03) : 323 - 332
  • [45] HMG-CoA reductase inhibitors/paracetamolLiver failure: 2 case reports
    Reactions Weekly, 2008, 1202 (1) : 18 - 18
  • [46] Expression of MDR1, MRP2 and BCRP mRNA in tissues of Turkeys
    Haritova, A. M.
    Schrickx, J.
    Lashev, L. D.
    Fink-Gremmels, J.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2008, 31 (04) : 378 - 385
  • [47] Downregulation of the hepatocellular organic anion transporters OATP-C and MRP2 in patients with primary sclerosing cholangitis
    Oswald, M
    Kullak-Ublick, GA
    Paumgartner, G
    Beuers, U
    JOURNAL OF HEPATOLOGY, 2000, 32 : 118 - 118
  • [48] Expression of the low-density lipoprotein receptor, HMG-CoA reductase, and multidrug resistance (Mdr1) genes in colorectal carcinomas
    Vitols, S
    Gunven, P
    Gruber, A
    Larsson, O
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (01) : 127 - 131
  • [49] HMG-CoA reductase inhibitors (statins) and acute kidney injury: A secondary analysis of renal study outcomes
    Wang, Amanda Y.
    Trongtrakul, Konlawij
    Bellomo, Rinaldo
    Li, Qiang
    Cass, Alan
    Gallagher, Martin
    NEPHROLOGY, 2019, 24 (09) : 912 - 918
  • [50] The effect of HMG-CoA reductase inhibitors (Statins) on PPAR and ABCA1 expression in cultured gallbladder epithelial cells
    Lee, J.
    Hong, E. M.
    Koh, D. H.
    Park, S. H.
    Choi, M. H.
    Jang, H. J.
    Kae, S. H.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S172 - S173
12345